Advanced cancer treatment increasingly relies on targeted therapies that act precisely on cancer cells. Unnati Pharmax, a trusted pharmaceutical exporter from India, supplies ERBITUX 500 mg Injection, containing Cetuximab 500 mg, a well-established monoclonal antibody therapy used in the treatment of specific cancers.
ERBITUX is widely prescribed in colorectal cancer and head & neck cancers, helping improve treatment outcomes when used alone or in combination with chemotherapy or radiation therapy.
What is ERBITUX 500 mg Injection?
ERBITUX 500 mg Injection contains:
-
Cetuximab – 500 mg
Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), which plays a key role in cancer cell growth and survival.
Uses of ERBITUX 500 mg Injection
ERBITUX Injection is commonly used in the treatment of:
-
Metastatic colorectal cancer (KRAS wild-type)
-
Squamous cell carcinoma of the head and neck
-
Advanced or recurrent head & neck cancers
-
EGFR-expressing tumors (as per oncologist recommendation)
It is often combined with chemotherapy or radiation therapy for better clinical outcomes.
How Does Cetuximab Work?
Cetuximab works by:
-
Binding to the EGFR receptor on cancer cells
-
Blocking signals that promote tumor growth
-
Inhibiting cancer cell division and survival
-
Enhancing the effectiveness of chemotherapy and radiation
This targeted mechanism helps slow cancer progression while minimizing damage to healthy cells.
Dosage and Administration
-
Administered via intravenous (IV) infusion
-
Dosage depends on body surface area and cancer type
-
Given under close medical supervision in a hospital or oncology center
⚠️ ERBITUX must be administered only by trained healthcare professionals.
Possible Side Effects
Some patients may experience:
-
Skin rash or acne-like eruptions
-
Infusion-related reactions
-
Fatigue
-
Diarrhea
-
Low magnesium levels
Side effects are monitored carefully during treatment.
Why Choose Unnati Pharmax for ERBITUX 500 mg Injection?
Unnati Pharmax is a reliable exporter of oncology and biologic medicines from India, supporting global cancer care.
Our Key Strengths
-
WHO-GMP compliant sourcing
-
Competitive international pricing
-
Complete export & regulatory documentation
-
Cold-chain and temperature-controlled logistics
-
Custom labeling and packing as per importing country norms
We export ERBITUX 500 mg Injection to Africa, Asia, Latin America, and other global markets.
Product Details
-
Product Name: ERBITUX 500 mg Injection
-
Active Ingredient: Cetuximab 500 mg
-
Dosage Form: Injection
-
Therapeutic Class: Anticancer / Monoclonal Antibody
-
Route of Administration: Intravenous
-
Packaging: Single-use vial (Export packing available)
FAQs – ERBITUX 500 mg Injection
What is ERBITUX Injection used for?
It is used to treat metastatic colorectal cancer and head & neck cancers that express EGFR.
Is ERBITUX chemotherapy?
No. ERBITUX is a targeted monoclonal antibody therapy, not traditional chemotherapy.
Can Unnati Pharmax export ERBITUX 500 mg Injection?
Yes. Unnati Pharmax exports ERBITUX Injection from India with full regulatory compliance.
Is ERBITUX a prescription medicine?
Yes. It is a prescription-only oncology medicine.
Can ERBITUX be administered at home?
No. It must be administered in a hospital or oncology clinic under medical supervision.
Conclusion
ERBITUX 500 mg Injection (Cetuximab 500 mg) is a globally trusted targeted therapy for colorectal and head & neck cancers. With a commitment to quality, safety, and international healthcare access, Unnati Pharmax ensures a reliable global supply of this advanced oncology medicine.
📩 Contact Unnati Pharmax today for export inquiries, bulk orders, or long-term oncology supply partnerships.PHONE8669251513
